DadFinStart your free weekPomdoctor Limited (POM) stock score
$1.17 ▼ -42.36% today
Pomdoctor Limited (POM) is a Pharmaceutical Retailers company in the Healthcare sector, listed in China. On DadFin's weekly run it scores 37.7 out of 100 on the Dad Score, a weak reading that places the business ahead of 38% of the 5,423 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #499 of 938. Its strongest axes are price action, liquidity and macro; its weakest are valuation and quality.
Scores from the run of Oct 25, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →
The eight axes
Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.
Key numbers
What subscribers see on POM
- Value Score: is the price right for this business, the score the Value book is selected on.
- Trader Score: is it set up to move, refreshed every 15 minutes in the session.
- The full eight-axis breakdown, every input and its percentile.
- SEC filings, insider buying, earnings history and peers side by side.
- Whether it is in this week's published books, with the receipts.
Healthcare peers
| Stock | Company | Dad Score | Band |
|---|---|---|---|
| LLY | Eli Lilly and Company | 95.4 | strong |
| JNJ | Johnson & Johnson | 97.1 | strong |
| ABBV | AbbVie Inc. | 99.9 | strong |
| UNH | UnitedHealth Group Incorporated | 93.8 | strong |
| MRK | Merck & Co., Inc. | 99.2 | strong |
| NVS | Novartis AG | 98.8 | strong |
| AZN | AstraZeneca PLC | 98.6 | strong |
| TMO | Thermo Fisher Scientific Inc. | 74.4 | good |
Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 25, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.